Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes

Jordana Phillips; Matthew M Miller; Tejas S Mehta; Valerie Fein-Zachary; Audrey Nathanson; Wendy Hori; Rita Monahan-Earley; Priscilla J Slanetz

doi:10.1016/j.clinimag.2016.12.011

Contrast-enhanced spectral mammography (CESM) versus MRI in the high-risk screening setting: patient preferences and attitudes

Clin Imaging. 2017 Mar-Apr:42:193-197. doi: 10.1016/j.clinimag.2016.12.011. Epub 2016 Dec 28.

Authors

Jordana Phillips¹, Matthew M Miller², Tejas S Mehta³, Valerie Fein-Zachary⁴, Audrey Nathanson⁵, Wendy Hori⁶, Rita Monahan-Earley⁷, Priscilla J Slanetz⁸

Affiliations

¹ Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: jphilli2@bidmc.harvard.edu.
² Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: matthew.miller@duke.edu.
³ Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: Tmehta@bidmc.harvard.edu.
⁴ Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: vfeinzac@bidmc.harvard.edu.
⁵ Clinical Research Center, Gryzmish 800, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: anathans@bidmc.harvard.edu.
⁶ Clinical Research Center, Gryzmish 800, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: whori@bidmc.harvard.edu.
⁷ Clinical Research Center, Gryzmish 800, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: rmonahan@bidmc.harvard.edu.
⁸ Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: pslanetz@bidmc.harvard.edu.

PMID: 28107737
DOI: 10.1016/j.clinimag.2016.12.011

Abstract

Purpose: Our study evaluates patient preferences toward screening CESM versus MRI.

Materials and methods: As part of a prospective study, high-risk patients had breast MRI and CESM. Patients completed an anonymous survey to evaluate preferences regarding the two modalities.

Results: 88% of participants completed the survey. 79% preferred CESM over MRI if the exams had equal sensitivity. 89% would be comfortable receiving contrast as part of an annual screening test.

Conclusion: High-risk populations may accept CESM as a screening exam and may prefer it over screening MRI if ongoing trials demonstrate screening CESM to be clinically non-inferior MRI.

Keywords: Breast cancer; Contrast-enhanced breast magnetic resonance imaging; Contrast-enhanced spectral mammography; High-risk screening.

MeSH terms

Attitude to Health*
Breast Neoplasms / diagnostic imaging*
Contrast Media
Early Detection of Cancer
Female
Humans
Magnetic Resonance Imaging / methods*
Mammography / methods*
Mass Screening
Middle Aged
Patient Preference*
Prospective Studies
Sensitivity and Specificity

Substances

Contrast Media